TLC analysis of intermediates arising during the preparation of oxime HI-6 dimethanesulfonate

Journal of Chromatographic Science

Volumn 46, Issue 4, 2008, Pages 316-319

  Jun, Daniel ^a,b   Stodulka, Petr ^a,c   Kuca, Kamil ^a,b   Koleckar, Vit ^a   Dolezal, Bohuslav ^c   Simon, Peter ^d   Veverka, Miroslav ^e  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

^c Vakos XT as   (Czech Republic)

^d SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

^e Bel/Novamann International Ltd   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 41749084868     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/46.4.316     Document Type: Article

References (20)

1. A.T. Tu. Chemical Terrorism: Horrors in Tokyo Subway and Matsumoto City. Alaken Inc., Fort Collins, CO, 2002.
2. L. Sevelova, K. Kuca, G. Krejcova, and D. Jun. Oximes in cyclosarin poisoning: Reactivation potency in vitro and therapeutic efficacy in vivo. Drug Met. Rev. 36: 99-99 (2004).
3. G.A. Petroianu, S.M. Nurulain, N. Nagelkerke, M. Al Sultan, A. Ain, K. Kuca, and J. Kassa. Five newoximes vs pralidoxime: Survival data from rats exposed to paraoxon. Crit. Care Med. 33: A52-A52 (2005).
4. M. Calic, A.L. Vrdoljak, M. Radic, D. Jelic, D. Jun, K. Kuca, and Z. Kovarik. In vitro and in vivo evaluation of pyridinium oximes: Mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity. Toxicology 219: 85-96 (2006).
5. K. Kuca, D. Jun, and J. Bajgar. Currently used cholinesterase reactivators against nerve agent intoxication: Comparison of their effectivity in vitro. Drug Chem. Toxicol. 30: 31-40 (2007).
6. K. Kuca, J. Cabal, D. Jun, and M. Hrabinova. In vitro evaluation of acetylcholinesterase reactivators as potential antidotes against tabun nerve agent poisonings. Drug Chem. Toxicol. 29: 443-449 (2006).
7. K. Musilek, K. Kuca, D. Jun, and M. Dolezal. Progress in synthesis of new acetylcholinesterase reactivators during the period 1990-2004. Curr. Org. Chem. 11: 229-238 (2007).
8. T.H. Kim, K. Kuca, and D. Jun. Design and synthesis of new bis-pyridinium oxime reactivators for acetyleholinesterase inhibited by organophosphorous nerve agents. Bioorg. Med. Chem. Lett. 15: 2914-2917 (2005).
9. P.M. Lundy, L. Raveh, and G. Amitai. Development of the bisquaternary oxime HI-6 toward clinical use in the treatment of organophosphate nerve agent poisoning. Toxicol. Rev. 25: 231-243 (2006).
10. G.A. Petroianu, S.M. Nurulain, N. Nagelkerke, M.A.H. Al Sultan, K. Kuca, and J. Kassa. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: survival in rats exposed to the organophosphate paraoxon. J. Appl. Toxicol. 26: 262-268 (2006).
11. G.Y. Yang, J.H. Yoon, C.M. Seong, N.S. Park, and Y.S. Jung. Synthesis of bis-pyridinium oxime antidotes using bis(methylsulfonoxymethyl) ether for organophosphate nerve agents. Bull. Kor. Chem. Soc. 24: 1368-1370 (2003).
12. I. Hagedorn, U.S. Patent 3,773,775 (1973).
13. I. Hagedorn, U.S. Patent 4,128,651 (1978).
14. H. Thiermann, S. Seidl, and P. Eyer. HI 6 dimethanesulfonate has better dissolution properties than HI 6 dichloride for application in dry/wet autoinjectors. Int. J. Pharm. 137: 167-176 (1996).
15. P.M. Lundy, I. Hill, P. Lecavalier, M.G. Hamilton, C. Vair, C. Davidson, K.L. Weatherby, and B.J. Berger. The pharmacokinetics and pharmacodynamics of two HI-6 salts in swine and efficacy in the treatment of GF and soman poisoning. Toxicology 208: 399-409 (2005).
16. U. Spöhrer and P. Eyer. Separation of geometrical syn and anti isomers of obidoxime by ion-pair high-performance liquid chromatography. J. Chromatogr. A 693: 55-61 (1995).
17. K. Musilek, K. Kuca, D. Jun, V. Dohnal, and M. Dolezal. Synthesis of a novel series of bispyridinium compounds bearing a xylene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase. J. Enzyme Inhib. Med. Chem. 20: 409-415 (2005).
18. K. Musilek, O. Holas, K. Kuca, D. Jun, V. Dohnal, and M. Dolezal. Synthesis of asymmetrical bispyridinium compounds bearing cyano-moiety and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase. Bioorg. Med. Chem. Lett. 16: 5673-5676 (2006).
19. K.A. Oh, Y. Yang, D. Jun, K. Kuca, and Y.S. Jung. Bis-pyridiniumaldoxime reactivators connected with CH2O(CH2)(n)OCH2 linkers between pyridinium rings and their reactivity against VX. Bioorg Med. Chem. Lett. 16: 4852-4855 (2006).
20. T. Csermely, G. Petroianu, K. Kuca, J. Furész, F. Darvas, Z. Gulyás, R. Laufer, and H. Kalász. TLC of quaternary pyridinium aldoximes, antidotes of organophosphorus esterase inhibitors. J. Planar Chromatogr. 20: 39-42 (2007).